Early Phase 1 Stomach Cancer Trial, Recruiting NCT07707531 Sponsor: Huashan Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Early Phase 1 Stomach Cancer Trial, Recruiting

NCT07707531
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • A written agreement to take part must be provided by the person themselves, their legal representative, or their caregiver.
  • People aged 18 years or older.
  • People who have been diagnosed with stomach cancer or pancreatic cancer through laboratory testing of tissue or cell samples, where the cancer shows a protein called Claudin 18.2 on the cancer cells.
  • People who have at least one area of cancer that tests positive for the Claudin 18.2 protein.

Who may not be able to join:

  • People who have received a treatment that can affect bone marrow within the last two weeks.
  • People with a known or suspected history of serious kidney or urinary system disease rated as severe (grade 3 or higher) (confirm with trial site).
  • People who have had an allergic reaction, sensitivity, or intolerance to radioactive medicines in the past.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Phone: +86 13764308300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Huashan Hospital
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
30 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Absorbed radiation dose (Gy) distribution in normal organs and tumors by quantitative SPECT/CT dosimetry

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov